RHL Group’s Cidara Therapeutics CDTX Stock Holding History

RHL Group’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2	Closed	-$442	–	243
2025 Q4	$442	Buy	+2	New	+$323	﹤0.01%	204

RHL Group's CDTX Position: Q1 2026 in Review

RHL Group sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 2 shares — an estimated $442 sold.

RHL Group first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $442 in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

RHL Group reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
RHL Group sold 2 Cidara Therapeutics shares in Q1 2026, an estimated $442.
RHL Group first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
RHL Group's Cidara Therapeutics position peaked at $442 in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on RHL Group's 13F filing for Q1 2026, filed 13 May 2026.